RE: Cloud cuckoo land.....12 Dec 2022 16:40
Again, this was 140-160 on submission of 510k. And it's one of the least sexy AIM stocks. Had it been P&D'd Aim style, it would have breached £2 easily.
On 510k news the price dropped to about 110 before the old II bailed into a panicking market (pussies).
Once there is a clear pathway to approval signed off by the FDA, this should be £2 less any possible dilution, on grafts alone.
Heart valve is believed to be the real asset here, but it's too early in development to translate into significant sp value unfortunately. General belief is that RUA won't be able to (or shouldn't even try) take it all the way to the end themselves but should be able to find a good jv partner or buyer for it.